Cyclerion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.About CYCN
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate.
CEORegina Graul
CEORegina Graul
Employees1
Employees1
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees1
Employees1
CYCN Key Statistics
Market cap6.67M
Market cap6.67M
Price-Earnings ratio-2.17
Price-Earnings ratio-2.17
Dividend yield—
Dividend yield—
Average volume8.80M
Average volume8.80M
High today$2.00
High today$2.00
Low today$1.65
Low today$1.65
Open price$1.91
Open price$1.91
Volume529.87K
Volume529.87K
52 Week high$6.25
52 Week high$6.25
52 Week low$1.16
52 Week low$1.16
Stock Snapshot
Cyclerion Therapeutics(CYCN) stock is priced at $1.73, giving the company a market capitalization of 6.67M. It carries a P/E multiple of -2.17.
As of 2026-01-12, Cyclerion Therapeutics(CYCN) stock has fluctuated between $1.65 and $2.00. The current price stands at $1.73, placing the stock +4.8% above today's low and -13.5% off the high.
The Cyclerion Therapeutics(CYCN)'s current trading volume is 529.87K, compared to an average daily volume of 8.8M.
During the past year, Cyclerion Therapeutics(CYCN) stock moved between $1.16 at its lowest and $6.25 at its peak.
During the past year, Cyclerion Therapeutics(CYCN) stock moved between $1.16 at its lowest and $6.25 at its peak.
People also own
Based on the portfolios of people who own CYCN. This list is generated using Robinhood data, and it’s not a recommendation.